retatrutide phase 2 trial type 2 diabetes results 2024 ada 2026: Revolution New clinical results show – retatrutide phase 2 trial type

Most patients find it quick and painless

Metabolism 63 (1), 919

Urinary frequency may change due to improved glycaemic control reducing osmotic diuresis, gastrointestinal side effects affecting hydration, or weight loss alleviating bladder pressure

Kidney or liver disease As the kidneys and liver help create and use L-carnitine, disease in these organs or organ failure Doctors may recommend L-carnitine supplementation in these cases to support the function of the kidneys and liver and prevent deficiency

Insurance and prior authorization Insurance coverage for retatrutide is not currently available through ordinary prescription-benefit channels because retatrutide is not FDA-approved for any indication